OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
July 29, 2024
The partnership—which features a $150 million investment—is also centered around vaccine development in the respiratory and immunology space.
A cohort study investigates whether or not the prevalence of these types of illnesses can vary among individuals who are COVID-positive versus negative.
The latest news for pharma industry insiders.
July 26, 2024
The pre-approval pertains to a solid oral dose product that the CDMO will manufacture for a global pharmaceutical company.
Making connections between different datasets is essential to developing impactful medicines and driving more personalized patient care.
July 25, 2024
The acquisition provides Ardian with greater insight into the life science industry.
The parties will continue to create new candidate therapies for the treatment of a severe form of TUBB4A leukodystrophy.
July 24, 2024
A deep dive into why this therapy has demonstrated effectiveness in various areas, including for tumors.